Çekiç, Şükrü, et al. “Vedolizumab Treatment in a Patient With X-Linked Agammaglobulinemia, Is It Safe and Efficient?”. The Turkish Journal of Pediatrics, vol. 61, no. 6, Dec. 2019, pp. 937-40, https://doi.org/10.24953/turkjped.2019.06.016.